CPT1A facilitates glutamine-independent growth of breast cancer cells by increasing the global lysine succinylation status in cells, especially the succinylation of enolase 1 at K80/81 and K335, which inhibits enolase activity. This evidence concerns the gene ENO1 and breast carcinoma.